Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
02/2002
02/07/2002US20020016365 Nonsteroidal gestagens
02/07/2002US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
02/07/2002DE10037146A1 Acetamidderivate Acetamide derivatives
02/07/2002DE10036852A1 Urethanderivate Urethane
02/07/2002DE10036121A1 N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate N-substituted-1-amino-1,1-dialkyl-carboxylic acid derivatives
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP1178037A1 Fungicidal phenylimidate derivatives
02/06/2002EP1178036A1 Fungicidal phenylimidate derivatives
02/06/2002EP1177442A1 Determination of complex phospholipid/lipid structures using synthetic fluorescence-marked acylglycerides
02/06/2002EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands
02/06/2002EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
02/06/2002CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors
02/06/2002CN1334807A 1-heterocycle substd. diarylamines
02/06/2002CN1334798A Phenylglycine derivatives
02/05/2002US6344485 Method for treating glaucoma
02/05/2002US6344484 Treatment of tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, and rheumatoid arthritis
02/05/2002US6344473 Imidazoles useful as nitric oxide synthase inhibitors
02/05/2002US6344454 Contraceptive preparations,treatment of endometriosis, gynecological disorders,premenstrual symptoms, male birth control, male hrt and hormone therapy and for treating andrological disease agents.
01/2002
01/31/2002WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens
01/30/2002EP1175383A1 Glucocorticoid receptor modulators
01/30/2002EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/30/2002CN1333754A Benzoheterocycles and their use as MEK inhibitors
01/29/2002US6342633 O-benzyl oxime ether derivatives and their use as pesticides
01/24/2002WO2002006256A1 Heterocyclic fluoroalkenyl thioethers (ii)
01/24/2002WO2002006250A1 Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists
01/24/2002WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
01/24/2002US20020010315 Treatment or amelioration of symptoms of adult respiratory distress syndrome, septic shock, and multiple organ failure.
01/24/2002US20020010286 Multifunctional cyanate ester and epoxy blends
01/24/2002DE10034131A1 Heterocyclische Fluoralkenylthioether (II) Heterocyclic fluoroalkenyl thioethers (II)
01/23/2002CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
01/22/2002US6340697 Oxime derivatives and agricultural chemicals containing the same
01/17/2002WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method
01/16/2002EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/15/2002US6339042 Herbicidal N-cyclohexadienyl heteroaryloxyacetamides
01/09/2002EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices
01/09/2002CN1330072A Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound
01/03/2002WO2002000612A1 Glucagon antagonists/inverse agonists
01/03/2002US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity
01/03/2002US20020002169 Protein kinase inhibitors
01/03/2002US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders
01/03/2002US20020001732 Polymer electroluminescent device
01/03/2002CA2411552A1 Glucagon antagonists/inverse agonists
01/02/2002EP1165721A2 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring
01/02/2002EP1165547A1 Substituted benzoylpyrazoles as herbicides
01/02/2002EP1165530A2 Dihetero-substituted metalloprotease inhibitors
01/02/2002EP1135151A4 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
12/2001
12/27/2001WO2001098283A1 Platinum-mediated synthetic process for δ4-1,2,4-oxadiazolines
12/27/2001WO2001097810A2 Use of therapeutic benzamide derivatives
12/20/2001WO2001096285A1 Beta-amino acid nitrile derivatives
12/20/2001US20010053774 Non-steroidal ligands for the estrogen receptor
12/18/2001US6331542 Protease inhibitors
12/18/2001US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
12/13/2001US20010051645 Thyroid receptor ligands
12/12/2001EP1162199A1 1,3,4-oxadiazole derivatives and process for producing the same
12/12/2001EP1161233A2 Lxr modulators
12/11/2001US6329371 α-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient
12/06/2001WO2001092241A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
12/06/2001US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists
12/06/2001DE10027025A1 Clycinamide Clycinamide
12/06/2001DE10027024A1 Carbaminsäureester Carbamic
12/05/2001EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/04/2001US6326403 Cardiovascular disorders
11/2001
11/28/2001EP1157985A1 Para- substituted phenylene derivatives and their use as integrin antagonists
11/28/2001EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001EP1156787A1 Oxadiazole compounds and compositions for delivering active agents
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001CN1075062C 乙酸衍生物 Acetic acid derivatives
11/14/2001EP1153922A1 Heterodiazinone derivatives
11/13/2001US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/08/2001WO2001083464A1 Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders
11/08/2001WO2001083438A2 New gamma selective retinoids
11/08/2001WO2001083431A1 Mmp-12 inhibitors
11/08/2001CA2407189A1 New gamma selective retinoids
11/07/2001EP1150978A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone
11/07/2001EP1150944A1 N2-phenylamidine derivatives
11/06/2001US6313115 Alleviate impairment of memory, or other cognitive functions caused by hypoglutamatergic condition or by deficiency in number or strength of excitatory synapses or in number of ampa receptors
10/2001
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149069A1 Phenylglycine derivatives
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/30/2001US6310107 (+)-6-(4-biphenylyl)methoxy-2-(2-(n,n-dimethylamino)ethyl)tetr alin, or a salt is useful for inhibiting production and/or secretion of amyloid-beta protein
10/25/2001WO2001078719A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied
10/25/2001CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/24/2001EP1148054A1 Thyroid receptor ligands
10/24/2001EP1147096A1 Herbicidal oxadiazolidines
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/23/2001US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001US6306881 Anti-inflammatory agents
10/23/2001US6306873 Substituted β-thiocarboxylic acids
10/23/2001US6306855 Fluoromethoximino compounds
10/18/2001US20010031772 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals
10/17/2001EP1144394A1 1-heterocycle substituted diarylamines
10/17/2001EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/10/2001EP1140791A2 Selective cpla 2 inhibitors
10/10/2001CN1316418A Benzene sulfonic derivative
10/10/2001CN1072660C 2,1,3-benzothia (oxa) diazole derivatives having endothelin receptor antagonistic effect
10/09/2001US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 72